ISG15
蛋白酵素
冠状病毒
干扰素刺激基因
干扰素
生物
免疫系统
病毒学
内部收益率3
泛素
基因
MDA5型
先天免疫系统
免疫学
遗传学
疾病
2019年冠状病毒病(COVID-19)
核糖核酸
医学
酶
RNA干扰
生物化学
传染病(医学专业)
病理
作者
Angeles C. Tecalco Cruz
出处
期刊:Current Drug Targets
[Bentham Science]
日期:2022-07-01
卷期号:23 (7): 686-691
被引量:4
标识
DOI:10.2174/1389450123666220316094720
摘要
Abstract: Interferon-simulated gene 15 (ISG15) belongs to the family of ubiquitin-like proteins. ISG15 acts as a cytokine and modifies proteins through ISGylation. This posttranslational modifica-tion has been associated with antiviral and immune response pathways. In addition, it is known that the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes proteases critical for viral replication. Consequently, these proteases are also central in the progression of coro-navirus disease 2019 (COVID-19). Interestingly, the protease SARS-CoV-2-PLpro removes ISG15 from ISGylated proteins such as IRF3 and MDA5, affecting immune and antiviral defense from the host. Here, the implications of ISG15, ISGylation, and generation of SARS-CoV-2-PLpro inhibitors in SARS-CoV-2 infection are discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI